We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Signs Drug Development Deal With Italian Biotech Firm BioXell
Merck Signs Drug Development Deal With Italian Biotech Firm BioXell
May 23, 2005
Merck has signed a multimillion-dollar drug development deal that will give it exclusive rights to a sepsis product candidate owned by Italian biotechnology firm BioXell.